Synusight Biotech (shanghai) Co., Ltd.

This early-phase study tests a new imaging drug called SST001 in 30 healthy adults and people with multiple system atrophy (MSA) or Parkinson's disease. The main goal is to check if SST001 is safe and how it spreads in the body using PET scans. Researchers hope it may help doctor…